You can watch ENLV and buy or sell other stocks, options, ETFs, and crypto commission-free!
Enlivex Therapeutics Ltd. develops autologous and allogeneic drug pipeline for treatment of autoimmune and inflammatory conditions. It produces treatment devices for CAR-T cancer treatment procedures, Graft-versus-Host disease resulting from bone-marrow transplantations, solid organ transplantations and an assembly of autoimmune and inflammatory conditions, such as Crohn's disease, rheumatoid arthritis, gout, multiple sclerosis and other disorders. Read More The company is headquartered in Nes-Ziona, Israel.
Nes-Ziona, Tel Aviv
52 Week High
52 Week Low
— per share